MILLER STRATEGIES, LLC

Lobbying for GILEAD SCIENCES, INC. · Biopharmaceutical company

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · California · $150,000.00 income · posted Apr 20, 2026

Lobbying activity 3

Health Issues

Issues related to pharmaceuticals and drug development.

Budget/Appropriations

Issues related to pharmaceuticals and drug development.

Medicare/Medicaid

Issues related to pharmaceuticals and drug development.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.